{"id":451647,"date":"2021-03-05T07:33:30","date_gmt":"2021-03-05T12:33:30","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=451647"},"modified":"2021-03-05T07:33:30","modified_gmt":"2021-03-05T12:33:30","slug":"agile-therapeutics-to-present-at-upcoming-march-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\/","title":{"rendered":"Agile Therapeutics to Present at Upcoming March Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">PRINCETON, N.J., March  05, 2021  (GLOBE NEWSWIRE) &#8212; Agile Therapeutics, Inc.\u00a0(Nasdaq: AGRX), a women&#8217;s healthcare company, today announced that Chairman and Chief Executive Officer Al Altomari will present at two investor conferences in March.<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>H.C. Wainwright Global Life Sciences Conference<\/strong><\/p>\n<ul type=\"circle\">\n<li>On demand beginning\u00a0Tuesday, March 9, 2021 at 7:00 a.m. ET<\/li>\n<\/ul>\n<\/li>\n<li>\n          <strong>Oppenheimer 31st Annual Virtual Healthcare Conference <\/strong><\/p>\n<ul type=\"circle\">\n<li>Wednesday, March 17, 2021 at 8:40 a.m. ET<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>Presentations from each conference will be webcast on the Investors section of the Agile Therapeutics website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hMyP7oP9a-A5Iaq05hIeoaxiOhR8KB5u2v74MVVwV94nu8_Ay7ch1SMlH35XwfwJyJh3-C_zCdptkFca__gcnlCQvlyemj-IQO0QF1YsTEQHyOCSVDR_z6N7B2PRLfIBZfGVkpD4fIHUBZk5p_ZBjOmnrTMEWLMX8CnXi2E8GE8VmwZ8OoAUgfJWx1hdCR66\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/ir.agiletherapeutics.com\/events-and-presentations<\/a>. Each archived webcast will be available for 30 days.<\/p>\n<p>\n        <strong>About\u00a0Agile Therapeutics, Inc.<\/strong><br \/>\n        <br \/>Agile Therapeutics\u00a0is a forward-looking women&#8217;s healthcare company dedicated to fulfilling the unmet health needs of today\u2019s women.\u00a0Our product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method.\u00a0Our initial product, Twirla\u00ae, (levonorgestrel and ethinyl estradiol), a transdermal system, is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion\u00ae, which is designed to allow drug delivery through the skin. For more information, please visit the company website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jtzYeJuImboH4B_nv1laTJphgGLf1_cMexHu07oSpIuVv68NEQvQjpWbfakOp9FRpj70pzyZ-2rls-tHFLVtjYx2qdW36_8OobKxth1r4rzud3IOEzkdTsHyLm3mmp1aP03g2aEg6TRuLFy-otqG7SKfDy_E7Yoc8niNVl6Nh7P6wnYlzOY5IIpmSvV5SWR1PyaRS__BkOgf-hqauSL7ZKof34hmCn3_EmJxfi5d5fagldW-dxCW4FSA3PNfk-MRByCp9azbfxUdF50UP6-UbPsSfPsl63kTu7Qo1QQk-zs=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong><u>www.agiletherapeutics.com<\/u><\/strong><\/a>. The Company may occasionally disseminate material, nonpublic information on the Company\u2019s website.<\/p>\n<p>\n        <strong>Contact:<\/strong>\u00a0<br \/>Matt Riley<br \/>Head of Investor Relations &amp; Corporate Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-NWn_-ptv-m-RqDJhl6SZZVAC8eaki-huJo-yzTlgolw6q2pgqcGTJOUTlMQtteXTd3jnKVFAVqINaltbNwP2HcouFxPxWgeHcAq-okWdQIjslCkpXO1BQUYUuyvrcf1\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong><u>mriley@agiletherapeutics.com<\/u><\/strong><\/a><\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDk3MyM0MDQ5ODgxIzIwMDc5MTY=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/4a3ef746-b7b9-4da1-ab1f-6fc660432683\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PRINCETON, N.J., March 05, 2021 (GLOBE NEWSWIRE) &#8212; Agile Therapeutics, Inc.\u00a0(Nasdaq: AGRX), a women&#8217;s healthcare company, today announced that Chairman and Chief Executive Officer Al Altomari will present at two investor conferences in March. H.C. Wainwright Global Life Sciences Conference On demand beginning\u00a0Tuesday, March 9, 2021 at 7:00 a.m. ET Oppenheimer 31st Annual Virtual Healthcare Conference Wednesday, March 17, 2021 at 8:40 a.m. ET Presentations from each conference will be webcast on the Investors section of the Agile Therapeutics website at\u00a0https:\/\/ir.agiletherapeutics.com\/events-and-presentations. Each archived webcast will be available for 30 days. About\u00a0Agile Therapeutics, Inc. Agile Therapeutics\u00a0is a forward-looking women&#8217;s healthcare company dedicated to fulfilling the unmet health needs of today\u2019s women.\u00a0Our product and product candidates are designed to provide women with &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Agile Therapeutics to Present at Upcoming March Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-451647","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Agile Therapeutics to Present at Upcoming March Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Agile Therapeutics to Present at Upcoming March Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PRINCETON, N.J., March 05, 2021 (GLOBE NEWSWIRE) &#8212; Agile Therapeutics, Inc.\u00a0(Nasdaq: AGRX), a women&#8217;s healthcare company, today announced that Chairman and Chief Executive Officer Al Altomari will present at two investor conferences in March. H.C. Wainwright Global Life Sciences Conference On demand beginning\u00a0Tuesday, March 9, 2021 at 7:00 a.m. ET Oppenheimer 31st Annual Virtual Healthcare Conference Wednesday, March 17, 2021 at 8:40 a.m. ET Presentations from each conference will be webcast on the Investors section of the Agile Therapeutics website at\u00a0https:\/\/ir.agiletherapeutics.com\/events-and-presentations. Each archived webcast will be available for 30 days. About\u00a0Agile Therapeutics, Inc. Agile Therapeutics\u00a0is a forward-looking women&#8217;s healthcare company dedicated to fulfilling the unmet health needs of today\u2019s women.\u00a0Our product and product candidates are designed to provide women with &hellip; Continue reading &quot;Agile Therapeutics to Present at Upcoming March Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-05T12:33:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDk3MyM0MDQ5ODgxIzIwMDc5MTY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Agile Therapeutics to Present at Upcoming March Investor Conferences\",\"datePublished\":\"2021-03-05T12:33:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\\\/\"},\"wordCount\":225,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDk3MyM0MDQ5ODgxIzIwMDc5MTY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\\\/\",\"name\":\"Agile Therapeutics to Present at Upcoming March Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDk3MyM0MDQ5ODgxIzIwMDc5MTY=\",\"datePublished\":\"2021-03-05T12:33:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDk3MyM0MDQ5ODgxIzIwMDc5MTY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDk3MyM0MDQ5ODgxIzIwMDc5MTY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Agile Therapeutics to Present at Upcoming March Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Agile Therapeutics to Present at Upcoming March Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Agile Therapeutics to Present at Upcoming March Investor Conferences - Market Newsdesk","og_description":"PRINCETON, N.J., March 05, 2021 (GLOBE NEWSWIRE) &#8212; Agile Therapeutics, Inc.\u00a0(Nasdaq: AGRX), a women&#8217;s healthcare company, today announced that Chairman and Chief Executive Officer Al Altomari will present at two investor conferences in March. H.C. Wainwright Global Life Sciences Conference On demand beginning\u00a0Tuesday, March 9, 2021 at 7:00 a.m. ET Oppenheimer 31st Annual Virtual Healthcare Conference Wednesday, March 17, 2021 at 8:40 a.m. ET Presentations from each conference will be webcast on the Investors section of the Agile Therapeutics website at\u00a0https:\/\/ir.agiletherapeutics.com\/events-and-presentations. Each archived webcast will be available for 30 days. About\u00a0Agile Therapeutics, Inc. Agile Therapeutics\u00a0is a forward-looking women&#8217;s healthcare company dedicated to fulfilling the unmet health needs of today\u2019s women.\u00a0Our product and product candidates are designed to provide women with &hellip; Continue reading \"Agile Therapeutics to Present at Upcoming March Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-05T12:33:30+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDk3MyM0MDQ5ODgxIzIwMDc5MTY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Agile Therapeutics to Present at Upcoming March Investor Conferences","datePublished":"2021-03-05T12:33:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\/"},"wordCount":225,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDk3MyM0MDQ5ODgxIzIwMDc5MTY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\/","name":"Agile Therapeutics to Present at Upcoming March Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDk3MyM0MDQ5ODgxIzIwMDc5MTY=","datePublished":"2021-03-05T12:33:30+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDk3MyM0MDQ5ODgxIzIwMDc5MTY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDk3MyM0MDQ5ODgxIzIwMDc5MTY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-present-at-upcoming-march-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Agile Therapeutics to Present at Upcoming March Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/451647","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=451647"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/451647\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=451647"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=451647"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=451647"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}